Loblaw Companies Limited · TSX:L
Loblaw Companies — Q4 2024 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Feb 20, 2025
Slide 1: Supplementary Slides Q4 2024
SUPPLEMENTARY SLIDES Q4 2024 For the periods ended December 28, 2024 and December 30, 2023 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q4 2024 (millions of Canadian dollars unless otherwise noted) Q4 2024 Q4 2023 % Change (1) Consolidated Revenue $14,948 $14,531 ↑ +2.9% Adjusted EBITDA $1,698 $1,633 ↑ +4.0% Adjusted EBITDA Margin 11.4 % 11.2 % ↑ 20bps Adjusted Net Earnings Avaliable to Common Sh
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q4 2024 (millions of Canadian dollars unless otherwise noted) Q4 2024 Q4 2023 % Change (1) Total Retail Revenue $14,579 $14,157 ↑ 3.0% Retail Revenue - Food $10,138 $9,774 ↑ 3.7% Retail Revenue - Drug $4,441 $4,383 ↑ 1.3% Pharmacy and Healthcare Services $2,230
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q4 2024 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +2.5% Basket Size(2) ↑ Traffic(2) ↑ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +1.3